Providence inScope
Clinical insights from Providence Health & Services
-
Read ArticleLooking ahead: Advancing a universal vaccine to prevent breast cancer
Exciting research is underway at Providence Cancer Institute focused on developing a universal breast cancer prevention vaccine. Learn how immunoprevention could change the future of cancer care.
-
Read ArticleLeadership change at Providence Cancer Institute, #FINISHCANCER goal remains
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
-
Read ArticleNoteworthy - December 2024
-
Read ArticleGamma Knife upgrade gives Providence Cancer Institute an edge in radiotherapy
The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.
-
Read ArticleDr. Walter Urba to retire
Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.
-
Read ArticleNoteworthy - September 2024
-
Read ArticleExpanding access to clinical trials in Hood River: The why and how
What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.
-
Read ArticleDr. Bernard Fox honored for his lifetime contributions to cancer research
This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.
-
Read ArticleNoteworthy - Summer 2024
-
Read ArticleAI-powered digital pathology model advances cancer research and diagnostics
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.
-
Read ArticleComprehensive care for long COVID patients still remains
Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.
-
Read ArticleNoteworthy - June 2024
-
Read ArticleInhibiting an inhibitor: NIH-funded study targets galectin-3 protein
A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.
-
Read ArticleRead the report: Providence clinical research innovations
-
Read ArticleNoteworthy - May 2024
-
Read ArticleMultiple sclerosis: Using artificial intelligence to expand MRI scan sensitivity
The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.
-
Read ArticleLooking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute
Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.
-
Read ArticleNoteworthy - March 2024
-
Read ArticleWinter Blues and Baby Blues: Can they lead to postpartum depression?
During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.
-
Read ArticleEndometrial cancer study aims to improve treatment options
A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.
-
Loading More...
